Describes the substances used to inhibit enzyme inhibitors from one or more families _) for Philadelphia-negative__lambda_ (true or idiopathic myelofibrosis_, primary thrombocytosis).The dosage of these substances is significantly lower than that of other types of syndromes. You may reach 10 to 150 mg / day / patient.
展开▼